Recruiting Thrombocytopenia Studies in Palo Alto
About Thrombocytopenia Clinical Trials in Palo Alto
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 2 thrombocytopenia clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 2,501 participants. Research is being sponsored by NICHD Neonatal Research Network, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Palo Alto — FAQ
Are there thrombocytopenia clinical trials in Palo Alto?
Yes, there are 2 thrombocytopenia clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated October 16, 2026 from ClinicalTrials.gov